Resolute Dermatology, LLC

Resolute Dermatology, LLC, based in the US, provides advanced dermatological products and services to address various skin conditions, aiming to improve patient outcomes through innovative treatments and comprehensive healthcare solutions. Resolute Dermatology, LLC offers specialized dermatological solutions, focusing on the management of skin conditions. Founded in 2020 in Overland Park, US, the company has completed 1 deal, with its most recent deal on February 23, 2026, when it was acquired by Epiphany Dermatology, P. A.

, a portfolio company of Leonard Green & Partners. Resolute Dermatology specializes in a range of dermatological products and services designed to address various skin conditions and improve patient outcomes. The company's core offerings include advanced dermatological treatments utilized by healthcare professionals to manage conditions such as acne, psoriasis, and eczema. Their products are engineered to provide effective solutions that enhance the quality of life for patients, with a strong focus on both efficacy and safety.

Resolute Dermatology’s clientele encompasses dermatologists, clinics, and hospitals, primarily located in North America and select regions in Europe, allowing them to reach a diverse patient population. Their commitment to innovation continues to drive the development of new therapies and formulations, ensuring they remain at the forefront of the dermatology sector. The revenue structure of Resolute Dermatology is grounded in direct sales to healthcare providers, including dermatologists and medical institutions. Transactions typically occur through established contracts, where healthcare providers purchase products based on patient needs and treatment plans.

This direct-to-consumer model allows for a streamlined purchasing process, ensuring that providers have timely access to critical dermatological treatments. Pricing strategies for Resolute Dermatology’s flagship products are tailored to reflect their innovative nature and are competitive within the market. The company focuses on fostering long-term partnerships with healthcare providers, enhancing customer loyalty and repeat business through effective product performance and support. Resolute Dermatology plans to continue its development of innovative dermatological products, with several new therapies currently in the design phase set to launch in the upcoming years.

As part of its expansion strategy, the company is focusing on entering new markets in Europe by 2027, aiming to broaden its client base. Recent funding from its acquisition will be directed towards supporting these new product launches and enhancing market presence.